Founder and CEO
Dr. Scott Whitcup is the Founder and CEO of Akrivista, a company focused on developing novel treatments in ophthalmology. Previously, he was EVP, R&D and Chief Scientific Officer at Allergan with experience running a large R&D organization with > 2500 employees and an annual budget of >$1B, and participated in many commercial launches. He has R&D expertise in ophthalmology, CNS, urology, dermatology, medical aesthetics, anti-infectives, and obesity. He has been extensively involved in business development, and has Board experience on both private and public companies.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.